Literature DB >> 11241711

Reanalysis of multislice (1)H MRSI in amyotrophic lateral sclerosis.

N Schuff1, W D Rooney, R Miller, D F Gelinas, D L Amend, A A Maudsley, M W Weiner.   

Abstract

The goal of this work was to reexamine previously published (1) brain spectroscopy data of abnormal metabolite ratios in amyotrophic lateral sclerosis (ALS). Toward this goal, (1)H MR spectroscopic imaging data from 10 ALS and nine control subjects were reanalyzed using improved data analysis techniques, including automated curve fitting and tissue-volume correction. In the motor cortex of ALS, N-acetyl aspartate (NAA) was 23% (P = 0.004) lower than in controls, and in the posterior internal capsule of ALS choline compounds (Cho) were 20% (P = 0.02) higher. This demonstrates that the metabolite ratio changes in ALS were due to NAA loss in the motor cortex (as expected) and Cho increase in the posterior internal capsule (not expected). Magn Reson Med 45:513-516, 2001. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11241711     DOI: 10.1002/1522-2594(200103)45:3<513::aid-mrm1067>3.0.co;2-d

Source DB:  PubMed          Journal:  Magn Reson Med        ISSN: 0740-3194            Impact factor:   4.668


  21 in total

Review 1.  Neuroimaging in amyotrophic lateral sclerosis.

Authors:  Sumei Wang; Elias R Melhem; Harish Poptani; John H Woo
Journal:  Neurotherapeutics       Date:  2011-01       Impact factor: 7.620

Review 2.  N-acetylaspartate as a marker of neuronal injury in neurodegenerative disease.

Authors:  Norbert Schuff; Dieter J Meyerhoff; Susanne Mueller; Linda Chao; Diana Truran Sacrey; Kenneth Laxer; Michael W Weiner
Journal:  Adv Exp Med Biol       Date:  2006       Impact factor: 2.622

3.  Presymptomatic spinal cord neurometabolic findings in SOD1-positive people at risk for familial ALS.

Authors:  J D Carew; G Nair; P M Andersen; J Wuu; S Gronka; X Hu; M Benatar
Journal:  Neurology       Date:  2011-09-21       Impact factor: 9.910

4.  Early detection and longitudinal changes in amyotrophic lateral sclerosis by (1)H MRSI.

Authors:  J Suhy; R G Miller; R Rule; N Schuff; J Licht; V Dronsky; D Gelinas; A A Maudsley; M W Weiner
Journal:  Neurology       Date:  2002-03-12       Impact factor: 9.910

5.  Proton magnetic resonance spectroscopy in patients with early stages of amyotrophic lateral sclerosis.

Authors:  Stefan Sivák; Michal Bittšanský; Egon Kurča; Monika Turčanová-Koprušáková; Milan Grofik; Vladimír Nosál'; Hubert Poláček; Dušan Dobrota
Journal:  Neuroradiology       Date:  2010-04-06       Impact factor: 2.804

6.  Cerebral degeneration predicts survival in amyotrophic lateral sclerosis.

Authors:  S Kalra; A Vitale; N R Cashman; A Genge; D L Arnold
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-07-11       Impact factor: 10.154

7.  Evaluation of treatment effects in Alzheimer's and other neurodegenerative diseases by MRI and MRS.

Authors:  S G Mueller; N Schuff; M W Weiner
Journal:  NMR Biomed       Date:  2006-10       Impact factor: 4.044

Review 8.  The path to biomarker-based diagnostic criteria for the spectrum of neurodegenerative diseases.

Authors:  Filippo Baldacci; Sonia Mazzucchi; Alessandra Della Vecchia; Linda Giampietri; Nicola Giannini; Maya Koronyo-Hamaoui; Roberto Ceravolo; Gabriele Siciliano; Ubaldo Bonuccelli; Fanny M Elahi; Andrea Vergallo; Simone Lista; Filippo Sean Giorgi; Harald Hampel
Journal:  Expert Rev Mol Diagn       Date:  2020-02-27       Impact factor: 5.225

9.  Multivariate statistical mapping of spectroscopic imaging data.

Authors:  Karl Young; Varan Govind; Khema Sharma; Colin Studholme; Andrew A Maudsley; Norbert Schuff
Journal:  Magn Reson Med       Date:  2010-01       Impact factor: 4.668

Review 10.  Neuroimaging biomarkers of neurodegenerative diseases and dementia.

Authors:  Shannon L Risacher; Andrew J Saykin
Journal:  Semin Neurol       Date:  2013-11-14       Impact factor: 3.420

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.